GVB Biopharma, a 22nd Century Group company (NASDAQ: XXII) has opened a new, strategically-located distribution facility in the Netherlands to support its growing business in Europe, the Middle East, and Africa. The new distribution facility will increase existing and new customer access to GVB’s quality hemp/cannabis products, speed up transaction flow, and optimize cross border tax and customs treatment.

Recent increases in GVB’s U.S. manufacturing capacity are complementary to the advent of the company’s Netherlands distribution facility. Additional capacity is in part …

Full story available on Benzinga.com